David Vulcano wants clinical research to report AI failures with the same rigor it applies to adverse events. Here’s why that call-to-action matters.
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Leveraging The Window Of Opportunity In Clinical Trial Recruitment
Access to real-world data now makes it possible to identify potential trial participants, wherever they are.
-
Control And Transparency: Solving Sponsors' Key Challenges In Study Launch
Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.
-
Improve Clinical Trial Management With Automated CTMS Tools
Uncover how advancements in clinical trial management systems signify a shift towards more streamlined and effective trial management and an enhanced quality and pace of medical research.
-
AI's Bottleneck In Clinical Trials Moved, And Most People Missed It
AI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.
-
AI Maturity In Clinical Development
The future of clinical research relies on operationalizing AI in a scalable, sustainable manner, ensuring that both technological and human factors are harmonized in this transformative journey.
-
Breakthrough Therapy Designation Accelerates Oncology Treatment Development
Find out how this evidence-generation company's solutions and scientific expertise enabled early and successful regulatory submission for a novel oncology therapeutic.
-
Automation Solutions For Safety Document Distribution
Discover how a leading global pharmaceutical company solved the problem of managed the distribution of safety reports by their clinical operations team.
-
One Day, We Won't Need Placebos
Embrace the future of clinical research by recognizing the limitations of traditional double-blind trials and exploring the transformative potential of real-world evidence (RWE).
-
Combining Patient-Centric Technology and RWD For Comprehensive Evidence
Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient.
-
Key Insights From The FDA's DHT Guidance
Check out a summary of the FDA’s guidance Framework for the Use of DHTs in Clinical Trials and what it means for sponsors and investigators using these innovative tools.
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
RECENT NEWSLETTERS
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech